Trial
NCT05791474
ATI-2231 in Advanced Solid Tumor Malignancies
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Washington University School of Medicine
Collaborators
Aclaris Therapeutics, Inc.
Condition
Advanced Solid Tumor
Intervention
ATI-2231
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-29